-
Atopic Dermatitis
- AKA eczema
- "The itch that scratches"
- Rash Itches->scratching->rash itches
- Highly pruritic
-
Atopic Dermatitis - Etiology
- Genetic component
- Family history of atopy (70%)
- Food allergies may worsen AD in children
- May b aggravated by topical irritation/affect skin barrier integrity
-
Atopic dermatitis triggers
- Irritants
- Allergens
- Perspiration
- Heat
- Tight clothing
- Rough fibers
- Emotional distress
-
Atopic Dermatitis - Epidemiology
- Most often onset in children
- Many children "outgrow" as they get older
- ~~May develop hand, eyelid, or postauricular dermatitis
-
Atopic Dermatitis - Pathophysiology
- T cells and Langerhans cells are hyperactive
- Causes defect in cell-mediated immunity and overproduction of immunoglobulins by B cells
- Barrier dysfunction
- Ceramide deficiency
-
Atopic Dermatitis ssx
- Erythema and severe pruritus
- Red pruritic papules, patches, and scaling
- May have vesicular lesions with acute onset
- Chronic lesions become lichenified
- Look for signs of superinfection
- Also more prone to viral and fungal skin infections
- Hyper or hypopigmentation may result
-
Atopic Dermatitis Infantile Distribution
- Cheeks, perioral, scalp
- Extensor surfaces of the knees and elbows
-
Atopic Dermatitis Childhood Distribution
- Flexural areas
- ~~Antecubital and popliteal fossae
- ~~Neck
- ~~Wrists, ankles
- May become lichenified
-
Atopic Dermatitis Adult Distribution
- Flexural involvement
- Hand dermatitis
- Eyelid or lip dermatitis
- Xerotic skin, ichthyosis vulgaris, keratosis pilaris
-
Nummular Eczema
- Round, coin-shaped eczematous lesions
- Most common in adults
- Sharply demarcated lesions on arms and legs
- Tends to recur when steroids with drawn
- One of the more difficult forms of eczema to treat
- DDx - fungal
-
Atopic Dermatitis - Diagnostic Evaluation
- Clinical diagnosis based on symptoms, exam, and family hx
- No labs needed
- Consider referral for allergy testing in children with severe or refractory AD
-
Atopic Dermatitis - Treatment
- Restore/protect skin barrier
- Topical steroids BID x 10-21 days-not a cure
- Topical immune modulators
- If pruritus severe, consider antihistamines PRN
-
Topical immune modulators-exzema
- Protopic (tacrolimus) or Elidel (pimecrolimus)
- Use twice daily for short term use, or intermittently for long-term use
- Used as steroid-sparing agents
- ?? Risk of CA
-
Atopic Dermatitis - Patient Education
- Moisture, moisture, moisture
- Limit baths to 5-10 minutes in lukewarm water
- Avoid triggers
- Symptoms will worsen with cool dry weather in the winter
-
Atopic Dermatitis - Old School and New School Treatments
- Bleach water baths
- Wet pajamas
-
Contact Dermatitis
- Allergic or irritant reaction caused by skin contact with a substance
- Rash will occur where the exposure occurs
-
Allergic Contact Dermatitis - Etiology
- Delayed (Type IV) hypersensitivity reaction
- Must be sensitized to a chemical before reactions occur
- Plants: Poison ivy, poison oak, poison sumac
- Metals: Nickel, chromate
- Rubber products
- Preservaties or addatives: Formaldehide, dyes, fragrances, quaternium-15, etc
-
Irritant Contact Dermatitis - Etiology
- Repeated exposure to mild irritants
- Water, heat, soaps, friction
- About 80% of cases of contact derm are irritant contact derm
- Nonspecific response - does not require sensitization
-
Contact Dermatitis presentation
- Initial: occurs w/in 14-21 d (allergic)
- subsequent rashes: occur more quickly after exposure
-
Irritant contact dermatitis presentation
- can present after one exposure to strong agents
- more frequently after repeated use of mild irritants
-
contact dermatitis ssx
- May have history of new exposure, but don't r/o if there is no "new" exposure
- Does the rash get better when away from work? Away from your hobby?
- May have photosensitization - sunlight + chemical = allergy ie Sunscreens
- Vesicles, edema, erythema, and extreme pruritus (allergic) or burning (irritant)
- As it becomes more chronic, becomes erythematous, scaling
- Occurs in area of contact initially, when chronic, may spread
-
Contact Dermatitis location-cause
- Face - make up, sunscreen, shampoo
- Eyelids - make up , nail polish
- Feet - leather (dye)
- Waist/umbilicus, finger, wrists, neck - nickel or metal
- Sun-distribution - photodermatitis
-
Rhus Dermatitis (contact)
- Caused by delayed hypersensitivity reaction to plants
- Poison ivy, oak, and sumac
- Linear vesicles and erythema
-
Contact Dermatitis - Diagnostic Evaluation
- Clinical Diagnosis
- If questionable, can biopsy (rarely needed)
- Consider patch testing
-
Patch Testing
- Tests for delayed hypersensitivity reactions
- Patches placed on patient's back
- Returns in 48 hours for first reading and removal of patches
- Returns again in another 48 hours for final read
- Standard panels or can customize panels
-
Contact Dermatitis - Treatment
- Allergen/irritant avoidance is mainstay of treatment
- Topical corticosteroids can treat acute symptoms
- Simplify skin regimen to avoid further irritation
- For severe cases, tapering course of oral prednisone or Medrol may be needed
- Allx can develop @ any time
- treatments control sx but do not eliminate allergies
-
Dyshidrosis
- Also called pompholyx, dishydrotic eczema
- Recurrent vesicular, eczematous dermatitis involving the hands and occasionally feet
- Cause is unknown
-
Dyshidrosis ssx
- Usually occurs in atopic patient
- Prodromal itching
- Hyperhidrosis may worsen condition
- Small vesicles (1-5 mm), monomorphic, filled with clear fluid="Tapioca like"
-
Dyshidrosis later
- As vesicles recede, develop scaling and peeling of skin
- Pruritus improves
- As healing occurs, may only have residual brown spots on an erythematous base
-
Dyshidrosis - Diagnostic Evaluation
- Clinical Diagnosis
- Pictures may be helpful - patient may not see you until they are in the later stages
- IF ONLY INVOLVES 1 HAND-EXAMINE FEET
- ID reaction - vesicular rash on one hand as an immune response to distant fungal infection
-
Dyshidrosis - Treatment
- High potency steroid
- Wet dressings or Burrow's solution
- Oral antihistamines for pruritus
- If result of ID reaction, treat fungal infection
-
Lichen Simplex Chronicus
- Chronic plaques with enhanced skin markings that result from chronic inflammation
- Caused by continued rubbing and scratching
- More common in adults
- may be present in children with longstanding eczematous conditions
-
LSC - Clinical Presentation
- Sharply demarcated, violaceous or red scaly plaques with lichenification
- On scalp, may present as sharply demarcated nodules
- Occurs most often in areas that can be easily reached
- ~~Lower legs, wrists, ankles
- ~~Posterior neck, scalp upper eyelids, behind the ear
- ~~Scrotum, vulva, and anal skin
-
LSC - Diagnostic Evaluation
- Clinical diagnosis
- DDx includes tinea - may need KOH stain to r/o
- Consider biopsy if lesion not straightforward
- Patch testing if caused by contact allergen or irritant
-
LSC - Treatment
- Patient reassurance
- Try to break the itch/scratch cycle
- Topical steroids may help thin plaque and reduce itching but will be of little use if the patient continues to rub the area
- Manage stress
- Awareness of scratching
- Consider oral antihistamines for nighttime scratching
-
Dermatitis Herpetiformis
- Vesicular disease seen in patients with gluten-sensitive enteropathy
- Uncommon in children
- Does not correlate with bowel symptoms
-
Dermatitis Herpetiformis - Clinical Presentation
- Clustered vesicles or excoriations
- on bilateral knees, elbows, sacrum, and base of the scalp-May only see excoriations
- HIGHLY pruritic, may be "burning" in nature
- May also have papules
- Generally, do NOT have bowel symptoms w/ their Celiac
- Less malabsorption than other pTs with Celiac
- Higher risk of lymphoma (as with other Celiac patients)
-
DH - Diagnostic Evaluation
- Biopsy: Direct immunofluorescence (DIF) - look for antibodies deposited in the skin
- Refer to GI - c-scope and biopsy
- May order celiac labs - positive in 70%
-
DH - Treatment
- STRICT GLUTEN AVOIDANCE
- Steroid to reduce inflammation
- Dapsone for recalcitrant cases
-
Bullous Pemphigoid
- Autoimmune disorder typically seen in older patients
- Subepidermal blistering
-
Bullous Pemphigoid - Etiology/Pathophysiology
- Autoimmune - antibodies against hemidesmosomal proteins
- Environmental trigger is often unknown
- May be triggered by certain drugs
-
Drugs trigger bullo0us pemphigoid
- Furosemide
- Captopril
- Some NSAIDs
-
Bullous Pemphigoid - Clinical Presentation
- Most commonly appears in flexural skin folds
- Starts with urticarial phase-Pruritic red papules coalesce and form plaques
- Within 1-3 weeks, plaques turn red, and bullae form
- "tense bullae on erythematous skin"
- Severe pruritus
- Bullae rupture within1 week, crust, then heal rapidly
- Negative nikolsky sign
- May also present with oral blisters (less commonly than in pemphigus vulgaris
-
Bullous Pemphigoid - Diagnostic Evaluation
- Biopsy
- ~~MARGIN OF BULLA
- ~~Include unaffected skin
- ~~Send for direct immunofluorescence (DIF) for immunologic stains
- May find circulating antibodies in the blood, DOESNTG CORRELATE TO DZ ACTIVITY
-
Bullous Pemphigoid - Treatment
- REFER TO DERM
- About half of patients are in remission at 3 years
- Treat the itch
- Hydroxyzine
- High-potentcy steroids
- Minocycline, tetracycline, dapsone, low-dose methotrexate, prednisone
-
Pemphigus Vulgaris
- Rare, potentially life-threatening autoimmune disease
- Intraepidermal blistering involving the skin and mucous membranes
- Occurs in older patients
- Highest incidence in people of Ashkenazi Jewish descent
-
Pemphigus Vulgaris - Clinical Presentation
- Initially develop oral lesions -weeks to months before skin symptoms
- Bullae 1-3 cm in size
- ~Minimally pruritic
- ~Tenderness or irritation of skin
- ~Rupture easily
- Most commonly involves torso, upper legs, can involve face and arms
- Nikolsky's sign
- dysphagia or sore throat d/2 blisters& erosions in pharynx/esophagus
-
Nikolsky sign
- Applying traction on intact skin causes formation of bulla
- Applying pressure to intact bulla causes it to extend into surrounding tissue
-
Pemphigus Vulgaris - Diagnostic Evaluation
- Biopsy: One from edge of lesion, one from unaffected skin&DIF
- Lab: May find antibodies in the blood
- CORRELATES WITH DZ ACTIVITY
-
Pemphigus Vulgaris - Treatment
- Treat any active infection (frequent cause of death)
- Prednisone, azathioprine (Imuran), cyclophosphamide
- Monitor for comorbidities of steroid
- Refer to derm (?tertiary care)
-
Acne Vulgaris
- Common polymorphous eruption seen on the face, chest, and back
- Most common during teenage years, but can persist into adulthood
- Hormone modulated
- Men have more severe disease but are less likely to seek treatment
- Women tend to have longer duration of disease
-
Acne Vulgaris - Etiology/Pathophysiology
- Pores become plugged (comedones)
- Secretions become stagnant, bacteria from surface of skin invade
- Immune response causes erythema, edema (pustules, papules)
- Deeper glands may be affected, causing deep, painful cysts
-
Acne Vulgaris - Aggravating Factors
- Genetics
- Diet (Dairy; Sugars?)
- Hormones
- Steroids
- Hygiene (yes and no)
- Chin straps, helmets
-
Acne Vulgaris - Clinical Presentation
- Noninflammatory lesions (Open and closed comedones)
- Inflammatory lesions (Papules, pustules, cysts)
- May cause scarring
- ~~Hyperpigmentation
- ~~Depressed scars
- ~~Sinus tracts from cysts
-
fx aggravate acne
- Women with hirsuitism and obesity - PCOS
- Young children - signs of secondary sex characteristics - precocious puberty
- Irregular menses in middle aged women - perimenopause
- Steroid use
- Bodybuilders/athletes - anabolic steroid use
-
Acne Vulgaris - Diagnostic Evaluation
- Clinical diagnosis
- Labs to r/o any associated conditions
-
Acne Vulgaris - Treatment
- Open pores
- Reduce bacterial load &/or inflammation
- Severe disease-isotretinoin
- Cystic acne usually requires oral medication
- Tailor medications to account for skin dryness, give your patient a plan to prevent dryness
-
Open the pores-acne
- Benzoyl peroxide
- Salicylic acid
- Retinoids
-
Reduce bacterial load &/or inflammation-acne tx
- Topical erythromycin combinations
- Oral doxycycline or minocycline
- Topical metronidazole or topical dapsone
-
Acne Vulgaris - Pearls for Treatment
- One med for opening pores, one med for bacteria, plus an oral antibiotic to have on hand for flares
- BUT fit the regimen to your patient
- Use combination products
- Lifestyle considerations; Consider the cost
-
Acne Vulgaris - Pt ed
- Let patient know the acne will get worse before it gets better
- Meds will take 6-8 weeks to have full effect
- No medi/combo is 100% effective
-
Acne Vulgaris - Treating Scarring
- Sunscreen
- Erythematous macules tend to fade over months: Bleaching cream, YAG laser
-
Pitting acne scars tx
- Deeper resurfacing laser
- Topical retinoids
- Dermal fillers
-
Acne Vulgaris - Prognosis
- Potential for significant psychosocial effects
- Acne is not just for teenagers!
- No significant long-term mortality, but can be costly in the long run
-
Rosacea
- Common facial rash with redness, blushing, telangiectasias, papules and pustules
- NO comedones
- Tends to occur during adulthood
- ~~Most commonly appears as perioral dermatitis in children
-
Rosacea - Etiology/Pathophysiology
- Exact cause unknown
- Demodex mite may contribute in some patients
-
rosaceaTriggers (especially for flushing)
- Hot food or drink
- Red wine
- Sunlight
- Skin irritants
- Embarrassment
- Spicy food
-
Rosacea - Clinical Presentation
- More common on fair skin types, but can occur with any skin type
- Patients tend to have "sensitive skin"
- Papules and pustules on forehead, cheeks, nose
- INVOLVES NASOLABIAL FOLDS
- Erythema and telangiectasias
- Rarely lesions anywhere but the face
-
Rhinophyma
- Enlargement of the nose due to chronic inflammation and skin thickening
- More common in men
- Rosacea SYMPTOM
-
Ocular rosacea
- May occur with or without skin disease
- Mild conjunctivitis
- ~~Erythema, discomfort, FB sensation, tearing
- ~~May cause blepharitis, chalazions, corneal vascularization over time
-
Rosacea - Diagnostic Evaluation
- Clinical Diagnosis
- If NL folds are spared, consider biopsy to r/u lupus
-
Rosacea - Treatment
- Avoid triggers
- Topical: Metronidazole; Sulfacetamide
- Systemic therapy: Low-dose doxycycline (Oracea)
- ~~May use full-dose tetracyclines for 2-4 weeks for exacerbation
-
Ocular rosacea TX
- Referral to ophthalmology
- Oral antibiotics
-
Treatment for erythema rosacea
- Cover with green cosmetics
- Laser or phototherapy
-
Rhinophyma tx
Surgery, CO2 laser
-
Folliculitis
- Inflammation of the hair follicle
- Caused by infection (bacterial or fungal) or irritation
-
Folliculitis - Etiology/Pathophysiology
- Inflammation of the hair follicle
- Infection with Staph
- Fungal folliculitis spread from other dermatophyte infection
-
Folliculitis - Clinical Presentation
- Abrupt onset of papules at the follicle
- Chest, scalp/face (areas that are shaved), legs, axillae, lower trunk
- May be painful or tender
- May have signs of dermatophyte infection elsewhere (fungal folliculitis)
-
Hot tub folliculitis
- Papules and pustules appear on torso after using a hot tub
- Caused by Pseudomonas
-
Folliculitis - Diagnostic Evaluation
- Clinical diagnosis
- KOH to rule out fungal
- ~~Fungal folliculitis tends to be more destructive
- May bacterial culture in recalcitrant cases
-
Folliculitis - Treatment
- Minimize heat, friction, occlusion
- Antibacterial soap, mupirocin ointment
- If extensive, consider dicloxacillin or cephalexin
- Oral antifungal therapy if fungal
- In recurrent cases, consider testing and treating for nasal S. aureus infection
-
Pseudofolliculitis Barbae "Razor bumps"
- Papular and pustular eruption due to close shaving
- More common in African Americans and Hispanics
- Sharp point of hair caught under skin, forms papule and irritation
- Treat by d/c shaving
-
Cellulitis
- Infection of the dermis and subcutaneous tissue
- Associated with systemic symptoms
- MC in immunocompromise, liver or renal disease, or use IV drugs or alcohol
-
Cellulitis - Etiology/Pathophysiology
- May occur as a result of wound, trauma, or break in the skin
- Break in skin may be relatively small and not apparent
- Deeper tissue layers are involved in the inflammatory reaction,
- ~~ causing erythema, edema, pain, warmth
-
Cellulitis - Clinical Presentation
- Initial symptom is localized pain
- Common sites are pinnae, lower legs, hands
- May have associated athlete's foot
- Develop red, swollen, painful plaque
- No distinct border
- May develop lymphangitis and adenitis (most commonly with S. pyogenes)
-
Cellulitis - Diagnostic Evaluation
- CBC - elevated WBC
- ESR elevated
- Culture: Group A Strep and S. aureus
- If animal bite or scratch, consider Pasturella
-
Cellulitis - Treatment
- Rest, elevation, ice
- Start empiric antibiotics (Staph and Strep)
- ~~Augmentin, Cephalexin, Azithromycin
- ~~Animal bite or scratch - Augmentin
- Hospitalization may be required for severe infection
-
Erysipelas
- Acute, superficial cellulitis with prominent lymphatic involvement
- Infection MORE SUPERFICIAL-DERMIS AND UPPER SUPCUTANEOUS TISSUE
-
Erysipelas - Etiology/Pathophysiology
- Infection most often results from break in tissue with entry of pathogens
- May not be able to identify the site of entry
- Staph and strep most common
- Those with immunosuppression, diabetes, poor circulation, or alcohol abuse more predisposed
-
Erysipelas - Clinical Presentation
- Prodrome of systemic symptoms
- Pain, burning, or tenderness
- Common areas - face, lower leg, arm
- Sudden onset of erythematous, tender, firm spot with sharply demarcated borders
- May have lymphatic streaking
-
Erysipelas - Diagnostic Evaluation
- Most cases due to Strep
- Clinical diagnosis - difficult to culture
- CBC - Elevated WBCs
- ESR - Elevated
- Consider blood cultures if high fever
-
Erysipelas - Treatment
- PENICILLIN V ORALLY IS DRUG OF CHOICE-azythromycin
- Bed rest, elevation, ice
- Consider prophylactic antibiotics for recurrent disease
- Consider hospitalization if rapidly advancing
- Treat underlying skin injury/condition
-
Impetigo
- Highly contagious SUPERFICIAL SKIN INFECTION
- Caused by S. pyogenes or S. AUREUS (MOST COMMON)
- May develop on damaged skin or normal skin
- Infections more common in children or those who are in close contact with others
-
Impetigo - Etiology/Pathophysiology
- Staphylococci from the skin and nose are introduced to broken skin
- May be due to underlying skin disease (i.e. eczema) or normal skin
- More common with poor hygiene or warm, moist climates
-
Bullous impetigo
- Thin-roofed bullae form
- As bullae collapse, a HONEY-COLORED CRUST FORMS
- Lesions may coalesce
- Lesions in many stages of healing
- mild adenopathy
-
Non-Bullous Impetigo
- Vesicles or pustules rupture and
- scaling, tinea-like border forms
- Honey colored or whitish crust forms
- May have satellite lesions around the periphery
-
Impetigo - Diagnostic Evaluation
- Culture
- S. aureus most common
- Need sensitivity information
-
Impetigo - Treatment
- Self-limited, but treat since it is highly contagious
- Limited disease (Bactroban)
- Widespread or bullous disease-Oral antibiotics
- ~~Dicloxacillin
- ~~Cephalexin
- Recurrent disease - consider culture of nose for carrier
-
Candidiasis
- Overgrowth of Candida albicans on the skin and/or mucous membranes
- Decreased cellular immunity, damaged barrier function, and changes in normal skin flora may predispose
-
Candidiasis - Risk Factors
- Diabetes
- Hormonal - pregnancy, OCP use
- Systemic antibiotics or steroids
- Skin maceration
- Conditions that affect cell-mediated immunity (viruses)
-
Candidiasis - Clinical Presentation
- Prefers to grow in warm, moist areas
- Affects only the outer layer of the skin
- ~~KOH scraping may show hyphae and pseudophyphae
- Beefy red lesion
- Cigarette-paper-like scale along advancing border
- Satellite lesions
- balanitis
-
Balanitis
- Foreskin and glans
- Red papules and pustules with pasty maceration under the foreskin
- Pain and edema
- Candidiasis sx
-
Diaper dermatitis
- Beefy red plaques in the inguinal and gluteal folds
- Satellite lesions
- candidiasis
-
Candidal Intertrigo
- Affects skin folds
- Develop beefy red plaques within the skin folds
- Advancing border - sharply defined
- Satellite lesions
- May have maceration of skin folds
-
Candidiasis - Diagnostic Evaluation
- KOH shows hyphae and pseudohyphae
- Culture may be positive for X
- Use judgment with culture X part of the normal skin flora
-
Candidiasis - Treatment
- Topical antifungals
- Dry the skin
- Fluconazole oral 200 mg day one, 100 mg days 2-7
- recurrent or severe dz: consider underlying predisposing condition
- DM? immunosuppression?
-
Tinea Versicolor
- Due to overgrowth of Pityrosporum orbiculare
- Normal skin flora
- Increased in oily skin, heat and humidity
- +/- contagious?
-
Tinea Versicolor - Clinical Presentation
- Common in teens, those with increased sebaceous activity
- More common in warmer climates, warmer weather
- Involves chest and back
- Different color on different skin tone (pink, hypopigmented)
- ~~uniform on pt; fine scale
- Woods light exam
-
Tinea Versicolor Wood's light exam
hypopigmented areas with a faint yellow-green fluorescence
-
Tinea Versicolor - Predisposing Factors
- DM, immunosuppression
- Pregnancy, OCPs
- Indoor tanning (Lower patient resistance)
-
Tinea Versicolor
- Clinical diagnosis
- Can do KOH to confirm
- ~~"spaghetti and meatballs pattern"
- ~~Hyphae break into short, rod-shaped fragments
- ~~Spores are round
-
Tinea Versicolor - Treatment
- Selenium sulfide shampoo, zinc pyrithion soap
- Antifungal cream or shampoo
- severe dz - fluconazole 150 mg twice weekly for 2 weeks
- ~~Sweating helps fluconazole work
- Skin pigment is slow to come back
- Patient reassurance
- Consider periodic shampoo washes to prevent recurrence
-
Onychomycosis
- Tinea infection of the nail plate
- Usually asymptomatic
- Increased risk with age
- Infection does not clear without treatment
-
Onychomycosis - Clinical Presentation
- Thickening of the nail plate, most commonly at the distal end
- Nail yellow, keratotic debris accumulates under the nail
- Nail separates from nail bed
-
Onychomycosis - Diagnostic Evaluation
- Culture of toenail reveals trichophyton spp.
- KOH of subungual debris shows hyphae
- Order CBC, LFTs before starting treatment (Lamisil) and after 6 weeks of treatment
-
Onychomycosis - Treatment
- Topical treatments rarely effective
- Oral therapy - Lamisil po daily
- ~~6 weeks fingernails
- ~~12 weeks for toenails
- Doesn't change appearance of old nails,
- only prevents infection of new nails
-
Dermatophyte infections-types
- Tinea Pedis-feet
- Tinea Corporis-body
- Tinea Cruris-jock strap
- Tinea Capitis-head
-
Dermatophyte Skin Infection
- MCC Microsporum, Trichohphyton, Epidermophyton
- Found in the keratinous layer of skin, hair, and nails
- May spread through contact or fomite
-
Dermatophyte Skin Infection - Clinical Presentation
- Erythematous papule/plaque
- As lesion enlarges, central clearing with an erythematous scaling papular or vesicular border
-
Tinea Pedis
- Most common form
- Warm, moist conditions predispose (Gym; Communal showers/baths)
- commonly affects interdigital webs
- may cause scaly infection on plantar surface or vesicles
- Moist skin between toes-Interdigital maceration
- Extends on the plantar surface of the foot
-
Plantar infection-tinea pedis
- Scaling affects all of plantar surface
- Fine scale with pink skin
- Pruritus
- May also involve the hands
-
Vesicular-tinea pedis
- May develop in patient with interdigital tinea pedis
- cover plantar or dorsal foot
- May trigger ID reaction
-
Tinea Cruris
- Affects crural fold
- May result from infection transferred from the foot
- Occurs in males
- HALF-MOON SHAPED ERYTHEMATOUS PLAQUE
- WELL DEFINED SCALE ALONG BORDER
- May migrate to buttocks and gluteal cleft
- Tinea Corporis
- Round annular lesions (Ringworm)
- Flat scaly papules
- Spread into plaques w/ central clearing and peripheral erythema and scale
- Periphery may also have papules or vesicles
- May coalesce to form plaques
- Epidemics may occur in wrestlers
- Severe/widespread dz-eval 4 immunosuppression or RF for fungal dz
-
Tinea Capitis
- Infection of the scalp, both the skin and hair follicle
- Acquired by close contact or sharing hair brushes
- Patchy white adherent scale on the scalp - mimics seborrheic dermatitis
- Inflammatory lesions may lead to alopecia
- Occipital adenopathy
-
Dermatophyte Skin Infection - Diagnostic Evaluation
- Scrape active border
- KOH stain - fungal hyphae
- Culture
-
Dermatophy infection culture
- Needed for hair or nail infection
- Swab active portion of the lesion
- Takes 4-6 weeks for results
-
Dermatophyte Skin Infection - Treatment
- Topical antifungal (pedis&cruris)
- Oral antifungals ( hair, nail, widespread)
- Powders to prevent reinfection
- Reduce RF
-
Exanthem
- Rash that occurs due to systemic disease
- Most commonly seen with viral infections
- Difficult to distinguish between viral cause
- A few viruses have characteristic rashes
-
Exanthems - Clinical Evaluation & treatment
- Get a good hx- consider time of year, outbreaks in the community, nonspecific symptoms that are associated
- Most common - erythematous maculopapular rash that is generalized, may coalesce into plaques
- Only symptomatic treatment needed
-
-
Roseola
- Young children (6 mos to 3 years)
- Caused by human herpesvirus 6 and 7
- Develop high fever
- As fever resolves, develop small, pink almond-shaped macules
- ~~ on the neck, trunk, proximal extremities, face
- Associated adenopathy
- Treat with symptomatic measures to control fever
-
Erythema Infectiosum (Fifth Disease)
- "Slapped cheek syndrome"
- Caused by parvovirus B19
- outbreaks in the winter and spring
- Most common ages 5-14
-
Erythema infectiosum ssx
- Rarely have prodromal symptoms
- Erythematous patches on the face "slapped cheek" with circumoral pallor
- Two days later, develop lacy, reticulated rash on torso
- May wax and wane for 2-3 weeks
-
Kawasaki disease
- Acute vasculitis
- Most commonly affects infants and children (7 wks-12 years)
- Conjunctivitis
- Lips and oropharynx
-
Conjunctivitis-kawasaki dz
Conjunctival injection; Uveitis
-
Kawasaki Disease-Lips and oropharynx
- become red 3-5 days later
- Lips dry, fissured, cracked
- "Strawberry tongue" - hypertrophic tongue papillae
-
Kawasaki Disease Skin findings
- 2-5 days after onset of rash
- -> erythema and edema of palms and feet
- ->followed by desquamation
- Rash begins with fever - polymorphous
- Generalized, diffuse deep red maculopapular lesions
- Diaper dermatitis and desquamation
-
Kawasaki Disease-Long term complication
- cardiac disease
- Abnormalities often resolve within a month, but sequelae may be long-lasting
- Cardiac involvement more common in males, patients < 1 yr or > 5 yr
-
Kawasaki acute phase complications
- half of patients develop myocarditis
- Tachycardia, gallop rhythm
- May lead to sudden death
-
Kawasaki Subacute phase complications
- 12-25 days after onset
- Coronary artery aneurysms and thrombi
- May cause stenosis as the inflammation resolves and scar forms
- Can lead to CHF, pericardial effusion, arrhythmia
- Death due to rupture of aneurysm or myocardial ischemia
-
Examthems-Diagnostic Criteria (need 5 of 6)
- FUO > 5 days
- Bilateral conjunctival injection
- Changes in lips and oral cavity
- Cervical lymphadenopathy
- Polymorphous exanthema with vesicles and crust
- Changes in peripheral extremities
-
Kawasaki disease-Treatment
- Aspirin
- IVIG
- If don't respond to IVIG, consider steroids
- Monitor for long-term cardiac side effects
-
Molluscum Contagiosum
- Localized viral infection of the skin spread by skin-to-skin contact
- Caused by a pox virus
- More common during childhood, teenage years
- More likely to occur or be more widespread in atopic patients
-
Molluscum Contagiosum- Clinical Presentation
- Small (1-2 mm) flesh colored papules that are dome shaped
- Evolve to become UMBILICATED, slightly larger (2-5 mm)
- May also become more pink
- Generally last 6-9 months without treatment, then resolve on own
- May occur as an STD in older population
-
Molluscum Contagiosum - Diagnostic Evaluation
- Usually a clinical diagnosis
- If atypical, consider bx
- Shows virus within the papule - "X body"
-
Molluscum Contagiosum - Treatment
- Limit skin-to-skin contact, sharing towels, etc.
- Cover lesions, avoid picking
- If treatment is required (or desired)
- ~~Curettage
- ~~Cryosurgery
- ~~Cimetidine given as an adjunct to enhance immune response
-
Herpes Simplex
- Viral skin infection caused by HSV I and HSV 2
- Type I - above the belt
- Type 2 - below the belt
- Not as true now
- After primary infection, the virus becomes latent in nerve ganglion, may develop recurrent disease at the same site
-
Herpes Simplex - Primary Infection
- Most often asymptomatic
- Often transmitted through respiratory droplets or direct spread
- If symptoms develop, occur after 3-7 days
-
Herpes simplex-sx
- Occur after 3-7days
- Prodromal pain, tenderness, paresthesias
- Lymphadenopathy, headaches
- Pharyngitis and gingivostomatitis if oral disease
- Vulvovaginitis, proctitis, anorectal pain if genital involvement
-
HSV - Primary Infection sx
- Grouped vesicles on an erythematous base
- More numerous in primary outbreak
- May occur on the skin or mucous membranes
- As vesicles rupture, crust forms
- Can last 2-6 weeks
- As rash resolves, virus migrates to nerve roots near area of infection, migrate to dorsal root ganglion and become latent
-
HSV - Recurrence
- May be precipitated by trauma, UV, illness, immunosuppression
- Prodromal symptoms
- Occur 2-24 hours before onset of rash
- Pain, paresthesia, burning sensation in the area affected
- Lesions develop - grouped vesicles on an erythematous base
- Vesicles umbilicate then rupture and crust
- Lasts about a week
- Systemic symptoms and lymphadenopathy rare
-
HSV - Common Locations
- Lips most common
- Herpetic whitlow (finger)
- Genital areas
- May occur anywhere on skin, but recurrences will happen in same area
- Does not protect the patient from developing HSV in other areas
-
HSV - Diagnostic Evaluation
- May make diagnosis clinically
- Culture vesicle
- ~~Unroof vesicle and obtain culture from base
- ~~Tzank smear - multinucleated giant cells
- ~~Rapid tests may be available
- ~~Can perform serology to determine HSV 1 or 2
- Culture may be negative
-
HSV - Treatment
- Prevent spread
- Will resolve without treatment - choice to treat can be individualized in healthy people
- In patients with recalcitrant or very active/widespread disease, consider source of immunocompromise
- Remind patient they are contagious, even with treatment
- May shed virus even when asymptomatic
-
Hsv Acute infection tx
- Valacyclovir (Valtrex) 1 g BID x 10 days
- Famciclovir (Famvir) 250 mg TID x 7-10 days
- Acyclovir 200 mg 5 x/day x 7-10 days
-
Hsv Recurrent infection tx
**Treat at first prodromal symptom**
-
HSV Suppressive therapy
- Consider based on number of recurrences/year (usually ~6)
- Lower dose antivirals taken daily to prevent outbreak
- If patient develops outbreak, switch to typical dose for outbreak, then back to lower doses
-
Varicella
- Initial infection caused by varicella zoster virus (herpesvirus)
- Highly contagious
-
Varicella - Etiology/Pathophysiology
- Human herpesvirus 3
- Transmitted by droplets
- Patients contagious for 2 days before onset of rash until lesions have crusted
-
Varicella - Clinical Presentation
- Prodromal symptoms - low-grade fever, malaise, headache
- Vesicular rash on trunk, spreads to face and extremities
- Highly pruritic
- Initially presents as small papule, becomes vesicle,
- then becomes umbilicated and cloudy.
- Ruptures and forms a crust-"Dew drop on a rose petal"
- Patients will have lesions in all stages of healing
- May have vesicles in mucous membranes - rupture to form aphthous ulcers
-
Varicella prodromal sx
- Low grade fever
- Malaise
- Headache
- Minimal in children
- More pronounced in adults
-
Varicella - Clinical Presentation
- Risk of bacterial superinfection
- Adults have more severe disease
- Pneumonia may develop in adults
- Immunocompromised may develop hepatitis
- Infection conveys lifelong immunity
-
Varicella - Diagnostic Evaluation
- Clinical diagnosis
- Can order Tzank smear if in question
- Bacterial culture if concern for secondary infection
-
Varicella - Treatment
- Symptomatic treatment for itching
- For severe disease, immunocompromised, consider oral medications
- Acyclovir at the first sign of symptoms
- Pregnant women who have been exposed should consider post-exposure prophylaxis due to risk of complications in the mother
- Less common now that vaccine is available
-
Zoster
- Reactivation of varicella zoster virus causes vesicular rash in a dermatomal distribution
- Generally involves one or adjacent dermatomes
- In immunocompetent individuals, generally does not cross the midline
-
Zoster - Etiology/Pathophysiology
- After varicella infection, virus migrates into the dorsal root
- May be reactivated with immune system insult
-
Zoster - Clinical Presentation
- Usually occurs in older individuals or those with decreased immunity or increased stress
- Prodromal pain and paresthesia (May occur up to 5 days before onset of eruption)
- Clusters of vesicles on an erythematous base along a dermatome or two adjacent dermatomes
- Other patterns associated with immuncompromise
- Most commonly affects thoracic region
-
Zoster - rash
- Vesicles may vary in size (are uniform size in herpes simplex)
- Crust over several days to weeks
- Post herpetic neuralgia
-
Zoster-Ocular involvement
- Hutchinson's sign
- Half will develop ocular complications without antiviral treatment
- Refer to ophthalmology
-
Zoster - Diagnostic Evaluation
- Culture available, but often false negative
- ~~Unroof vesicle, culture base of lesion
- Tzank smear - multinucleated giant cells
-
Zoster - Treatment
- Steroids for pain (does NOT decrease incidence of PHN)
- Oral antivirals
- Treatment for PHN (if develops)
- ~~Gabapentin
- ~~Amitriptyline
- ~~Topical capsaicin
-
Zoster - Vaccination
- Zostavax indicated for individuals > 60 years old
- ~~Reduces risk of Zoster by 51%
- ~~Reduces risk of PHN by 67%
- Live vaccine-Avoid in immunocompromised individuals
- Expensive, insurance coverage variable
- Difficult for people outside of guideline age to receive
-
Condyloma Acuminatum
- Genital warts
- Infection caused by human papilloma virus
-
Condyloma Acuminatum - Etiology/Pathophysiology
- Spread by direct contact
- Increased transmission in moist areas
- Virus is present on normal skin that is contiguous to wart
-
Condyloma Acuminatum - Clinical Presentation
- May differ in appearance from one person to another
- Pale pink, white, or brown papules with rough surface
- May be just barely raised
- May have papillae or filiform look
- Small lesions may look smooth or velvety
- Coalesce in rectal or perineal to form cauliflower-like mass
- May extend into internal mucosa
-
Condyloma Acuminatum - Diagnostic Evaluation
- Clinical diagnosis
- Can biopsy
-
Condyloma acuminatum - Treatment
- Cryotherapy
- Electrodessication and curettage
- Podofilox (Condylox gel)-3 days on, 4 days off x 4 weeks
- Imidquimod cream (Aldara)
-
Condyloma Acuminatum - Patient Education
- Use of condoms reduces spread by 95%
- Have partners checked
- Warts caused by HPV 6, 11
- Cervical cancer caused by HPV 16, 18
- Recommend pap smear
- Warts in children under 3 may be transmitted perinatally. In older children, consider sexual abuse
-
Verrucae
- Verruca vulgaris - "warts"
- Caused by HPV
-
Verrucae - Etiology/Pathophysiology
- Spread by contact
- Inoculation occurs with simple trauma to the skin
- Must reach basal epithelial cells in order to occur
-
Verrucae - Clinical Presentation
- Flesh-colored papules raise up
- May be black, brown
- Have rough surface and disturbance of normal skin lines
- Black dots - thrombosed capillaries
- May be solitary or numerous
-
Filiform warts
- finger-like projections
- more common on the face
-
Flat warts-verrucae
- Thin, less scaly
- Still have disruption of normal skin lines
- Found in patches with contiguous spread due to repeated trauma
-
Plantar warts-verrucae
- More common at points of pressure
- Depressed or flat, loss of normal skin markings
- Tender
- "Kissing lesions" on adjacent toes
- Much more refractory to treatment
-
Verrucae - Diagnostic Evaluation
- Typing is not clinically helpful
- Biopsy if not healing AND sun exposed skin (r/o scc)
-
Verrucae - Treatment
- May resolve on own (2/3 regress w/in 2 yrs in kids)
- Less likely to resolve in immunocompromised
- No one "treatment of choice"
- Salicylic acid topically;+/- tape occlusion
- ~~Treatment for 8-12 weeks
- Cryotherapy
- Imiquimod (Aldara)
- Electrocautery and curettage
- Laser treatment
-
Verrucae - Clinical Pearls
- Patient education about spread
- ~~Shaving, picking, biting
- No tx 100%
- most rely on activating the body's own immune defense
-
Seborrheic keratosis
- Benign, persistent epidermal lesion
- Variable clinical appearance
- One of the most commonly encountered lesions
-
Seborrheic Keratosis - Etiology
- Increased incidence with age (rare before age 30)
- Tendency toward multiple often inherited
-
SK - Clinical Presentations
- Varied-Most often asymptomatic
- Pruritic, may be irritated by clothing
- Often cosmetically unappealing
- Usually multiple lesions
-
Sk apperance
- anywhere but palms, soles, or lips-Common on arms, back, face
- 0.2-2.0 cm in diameter
- black, brown, skin colored
- Flat or raised with a smooth, warty, or oily texture
- Sharply demarcated with a "stuck on" appearance
-
Leser-Trelat
- Sudden, explosive onset of multiple SKs
- Associated with internal malignancy
-
SK - Diagnostic Tests
None necessary unless lesion has suspicious characteristics
-
SK - Treatment
- No treatment needed
- May remove/tx due to cosmetics or irritation/inflammation
- ~~Salicylic acid
- ~~Cryosurgery
- ~~Shave excision
-
Sk Prognosis
- Benign process with no malignant transformation
- HOWEVER - have been cases of melanoma, basal cell, or squamous cell arising within an SK
- If lesion has changed or have clinical suspicion - biopsy it!
-
Actinic Keratosis
- Keratotic, precancerous lesions
- Precursor to squamous cell carcinoma
- Most commonly seen in areas of sun exposure
- More common in those with high lifetime exposure, fair skin types, elderly
-
Actinic Keratosis - Etiology/Pathophysiology
- Sun exposure damages keratinocytes-> dna error
- More sun-> localized immunosuppression -> more damaged DNA
- Over time, may lead malignant transformation
- (10% ->SCC if untreated)
- Increased risk in transplant patients
-
Actinic Keratosis ssx
- Patients > 40 y/o with fair skin types
- "scab" or "dry skin" that won't heal or keeps recurring
- Most commonly seen on face, scalp (if bald), neck, dorsum of the hands
- Initial: poorly demarcated erythema
- Later: more defined, develops a thin, adherent white or yellow scale
- ~~May be easier to detect by palpation
-
Actinic Keratosis ssx progression
- Scale becomes thicker, more yellow
- May form cutaneous horn as scale builds up
- Advanced lesions impossible to distinguish from SCC
-
Pigmented AK
- pigmented lesion with fine scaling
- May resemble solar lentigo or melanoma in situ
-
Actinic chelitis
- Involves lower lip
- Focal crusting or scaling
- Higher chance of progressing to SCC
-
AK - Diagnostic Evaluation
- Biopsy if suspicious of SCC
- Most often clinical diagnosis
-
AK - Treatment
- Annual follow up
- Sun protection/sun avoidance
- Few lesions: Cryotherapy; Biopsy or shave if suspicious
-
AK tx multiple lesions
- Visible lesions are only a small portion of cells with atypia
- Likely that these patients will develop further lesions
- Patients with multiple AKs have 20% risk of developing SCC
- "treat the field"
-
5-fluorouracil (5-FU)
- Treat field AK
- Causes immune response to atypical cells
- "hidden" become red, inflamed, ooze
- Course of treatment - 3 weeks, then skin clears
- Also available - Imiquimod cream
-
Squamous cell carcinoma
- Primary cutaneous malignancy arising from keratinocytes of the skin and mucous membranes
- Most often seen in elderly, fair skin types, those with high cumulative sun exposure
- May arise from AKs or de novo
-
SCC - Etiology, Epidemiology
- Sun exposure
- Lifetime risk - 5-15%
- 100,000 new cases each year in the US, 2,500 deaths yearly due to metastasis
- Increased risk in transplant patients and those who are immunosuppressed
-
SCC ssx
- Most commonly-face, head, neck, hands
- Surrounding skin is sun damaged
- Initial: appear like hypertrophic AK
- Pink or red, dome-shaped nodule with adherent yellow-white scale
- Progression: increases in size and develops necrotic, crusted center
-
Scc variants
- Bowen's disease-full-thickness SCC in situ
- Cutaneous horns
- Keratoacanthoma-crater-like nodule w/ necrosis
-
Keratoacanthoma
- Large, nodular, crater-like nodule with central necrosis
- Fast growing
- Low-grade variant of invasive SCC
-
SCC - Metastasis
- More likely on mucous membranes or more advanced lesions
- Mets first to regional lymph nodes
- ~~Usually within 2-3 years of skin lesion
-
SCC - Diagnostic evaluation
- Biopsy suspicious lesions
- Deep shave (include dermis)
- Electrocautery and curettage to remove residual cells
- Deeper lesions may require excision with clear margins
-
SCC - Treatment
- Excisional biopsy (shave or excision with clear margins) is diagnostic as well as therapeutic
- Increased surveillance for other malignant or premalignant skin lesions
- Monitoring of the scar site for recurrence
- May require MOHS surgery
- Palpate regional lymph nodes, lip if affected
-
SCC - Prognosis
- Excellent if adequately treated, not metastatic
- Increased risk of metastasis in immunosuppressed patients, lesions on lip or ear, or arising from scar tissue
-
Basal cell carcinoma
- Primary skin malignancy arising from the basal layer of keratinocytes
- Most common cutaneous malignancy
- Untreated, will invade and destroy surrounding tissue
- Rarely metastasize
-
BCC - Etiology, Epidemiology
- Sun exposure
- More common later in life, lighter skin types
-
BCC ssx
- Most commonly appear in sun-exposed areas - face, scalp, ears, neck
- Pink, violaceous, or pearly white nodules
- May appear translucent
- Overlying telangiectasias
- Rolled borders and central ulceration as lesion progresses
- Bleed, become crusted, or ulcerate
- May notice "mushy" texture during curettage
-
Pigmented BCC
- May have pigmented area or be fully pigmented
- Prognosis same as nonpigmented
-
Superficial BCC
- Thinnest, least aggressive
- Appear in younger patients
- May also appear on the trunk or extremities
- Flat, may appear atrophic
- Spreads peripherally
-
BCC - Diagnostic Evaluation
- Biopsy it!
- Shave biopsy with curettage
-
BCC - Treatment
- Excision of lesion can be diagnostic and therapeutic
- Cryotherapy - if superficial
- Shave biopsy with electrodessication and curettage
- Excision
- MOHS surgery
- Rarely radiation - based on location, patient's ability to tolerate surgery
- Imiquimod cream (Aldara), 5-FU (Carac, Efudex) -superficial
-
Imiquimod/5-FU cream
- Superficial bcc
- Use daily x 6 weeks
- Causes significant inflammation
-
BCC - PT ed and Prognosis
- Reassure patient
- Sun avoidance/sun protection
- Regular skin evaluation for further effects of sun damage
-
Benign Nevi
- Benign skin tumors composed of melanocyte-derived nevus cells
- Appear at birth or within first two years - congenital
- Acquired nevi occur throughout life, peak during adolescence
- Sun exposure can stimulate growth
- May change appearance over years-decades
-
Junctional Nevi
- Nevus cells at the dermoepidermal junction
- Flat or slightly raised
- Skin markings are preserved
-
Compound Nevi
- Nevus cells at the dermoepidermal junction and within the dermis
- Raised pigmented papules
- Surface is smooth or slightly warty
- Center is more heavily pigmented than the periphery
- Increase in thickness during childhood and adolescence
-
Intradermal Nevi
- Nevus cells within the dermis, may extend to subcutaneous tissue
- Papules that are flesh colored to slightly pigmented to dark brown
- May have coarse hair growing from them
- Develop after adolescence
-
Blue Nevi
- Blueish macules or papules due to deeply pigmented melanocytes in the deep dermis
- Most commonly seen on the head, neck, buttocks
- Present early in childhood, enlarge and persist for 10-15 years
-
Halo Nevi
- Preexisting nevus develops an annular ring of hypopigmentation
- Over several months, the nevus disappears
- Caused by lymphocytic infiltration - host response against nevus cells
- May be seen in patients with vitiligo or melanoma - require full skin exam
-
suspicious?
- Asymmetry
- Border
- Color
- Diameter
- Evolution
- Does it bleed (without injury)
- Ulceration
-
Nevi - Treatment
- Most require no treatment
- If suspicious - biopsy it
- ~~~Punch or excision; May consider deep shave
- Get clear margins
- Patient reassurance
- Multiple or RF 4MM=more routine skin surveillance
-
Dysplastic Nevi
- Nevi with potential for malignant transformation
- Cellular architecture is disordered but cells have mild or no atypia
- May be isolated or have multiple dysplastic nevi
- Isolated dysplastic nevus is fairly common (5-20%)
- Continue to appear through adulthood
-
Dysplastic Nevus Syndrome
- Familial syndrome of multiple atypical nevi
- Associated with increased risk of melanoma
- Relatively uncommon
- nearly 100% lifetime risk of MM by age 70
-
Dysplastic Nevi - Clinical Presentation
- One or multiple irregular nevi (ABCDE's)
- Patients with dysplastic nevus syndrome have multiple nevus morphologies
- Tend to be larger (6-15 mm)
- May be maculopapular
- Often have nevi in sunprotected areas
-
Dysplastic Nevi - Diagnostic Evaluation
- Only way to diagnose - Biopsy it!
- Excision
- Regular skin exams
- Lifetime risk of MM in general population - 1.3%
- Lifetime risk of MM in pt with atypical nevi (without family hx of MM) - 6%
-
Dysplastic Nevi - Treatment
- Excise suspicious nevi
- Sun protection/avoidance
- Skin exams every 6-12 months (including sun-protected areas)
- Baseline eye exam
- Self monitoring with skin exams
-
Melanoma
- Primary skin malignancy affecting the melanocytes
- Curable with early detection and treatment
- Often fatal if caught late (15% 5 year survival rate)
- Only 2% of skin cancer cases but causes 75% of deaths due to skin cancer
-
Melanoma - Epidemiology
- Most common form of cancer in age 25-29, second most common form of cancer for adolescents
- More common, increasing more in females
- Approximately 120,000 new cases yearly
- 8600 deaths yearly (one every 61 minutes)
- Rate of MM increasing more quickly than any other cancer
-
Melanoma - Risk Factors
- Fair skin (Types I and II)
- Atypical nevi in both sun exposed and sun protected areas
- Personal history of MM
- Family history of atypical nevi or MM
- History of blistering sunburn
- Congenital nevi (risk increases with size)
-
Melanoma ssx
- Increase in size, shape, or color of existing lesion (30%)
- May occur as a new lesion (70%)
- Usually asymptomatic early-May itch
- As progresses, develops tenderness, bleeding, and ulceration
- Appearance varies
- Darker skin tones are not 100% protective
- Check palms, soles, mucous membranes, nails
- Focal area of color change within a preexisting lesion
- Look for the ABDCEs
-
Superficial Spreading MM
- Most common (70-80%)
- Most mm arise from preexisting lesions are X
- Lesions spread laterally over the skin before becoming nodular
- Most common on trunk and extremities
- Flat, asymmetric, color variation, >6 mm
-
Nodular
- 10-15%
- More common on extremities
- Brown-black raised papules that appear and grow rapidly
- May have focal hemorrhage
- Tend to extend vertically in the skin
-
Lentigo maligna
- 5-10% of cases
- Melanoma in situ
- Develop over years/decades on sun exposed skin
- Flat, irregular, variation in pigment
- May look "washed out" in areas or be skin colored
-
Acral lentiginous melanoma
- Occurs in all skin types (including IV-VI)
- Most common melanoma in Asians and African Americans
- Occurs on hands or feet (including nails)
- May have similar lesions around the mouth, anus, or genitalia
-
MM - Diagnostic evaluation
- BIOPSY!!-Full thickness, try to get clean margins
- Palpate regional nodes for any adenopathy
- Breslow level:
-
Breslow level
- For MM dx
- Measure of vertical thickness of the melanoma
- Most important prognostic factor
- Ulceration of the lesion may cause an underestimated Breslow level
-
MM - Treatment
- Remove it! - complete lesion into subcutaneous fat
- Melanoma in situ - reexcision with 0.5 cm margins
- Lentigo maligna - may have microscopic extension - consider MOHS
- Consider sential node biopsy in patients with Breslow level > 1.0 mm
- More advanced disease may require chemotherapy
- Lots of experimental trials of chemotherapy ongoing
- Patients need regular skin exams (every 3-6 months), biopsy of other suspicious moles
- Baseline chest x-ray, palpation of lymph nodes and liver
- First degree relatives should have regular skin screening
-
MM - Prognosis
- Better prognosis with lower Breslow depth
- 95% 5-year survival with Breslow < 1.0 mm without ulceration
- 7-19% 5-year survival with distant metastasis
- Prevention and early detection is key!
-
Kaposi Sarcoma
- Malignancy of lymphocytic endothelial cells
- Associated with a gamma herpesvirus
- Before advent of immunosuppressive medications, uncommonly seen
- ~~Sporadic in men of Eastern European or Mediterranean descent
- ~~Eastern and southern Africa - endemic cases of childhood soft tissue tumors
- With immunosuppression, patients of Mediterranean and eastern European descent more likely to develop than other patients
- Much more wide spread as an HIV-related malignancy
- Most common AIDS-associated malignancy
-
Kaposi Sarcoma - Clinical Presentation
- Polymorphic, can vary with clinical variant
- Start as purple patches that may thicken and darken into brown verrucous patches
- Classic and immunosuppressive starts at the feet/ankles, spreads proximally
- May affect lymph nodes, gi tract and lungs
-
AIDS-related Kaposi
- most often found on the face
- May affect lymph nodes, GI tract, lungs
- more likely to have systemic symptoms
-
Kaposi Sarcoma - Diagnostic Evaluation
- Biopsy to confirm
- HIV test (if not known HIV), CD4 count
- Oral evaluation - often oral lesions in patients with HIV
-
Kaposi Sarcoma - Treatment
- Excision of single lesion
- Radiation if multiple lesions
- Extensive lesions may also require chemotherapy
- Consider d/c immunosuppressive therapy
- AIDS-associated - Radiation therapy, cryotherapy
-
Drug Eruptions
- Reaction to drugs taken internally
- Multiple morphologies
- May occur w/new med or one taken for months-years
- Once sensitized, usually react within minutes up to 24-48 hours
- May be due to hypersensitivity reaction (Types I-IV) or nonimmunologic cause
-
Morbiliform Drug Eruption rash
- Maculopapular
- Erythematous macules and papules become confluent
- Symmetric, generalized
- Usually spares the face
- May involve mucous membranes, palms, soles
- Pruritic
-
Morbiliform Drug Eruption
- Most common presentation
- May be indistinguishable from viral rash
- Starts 7-10 days after drug is started
- Lasts 1-2 weeks before resolving
-
Urticarial Drug Reaction
- Most common causes ASA, NSAIDs, PCN, blood products
- Includes anaphylactic reactions, serum sickness
- May have immediate reaction (anaphylaxis) or occur hours to days later
- Certain medications trigger histamine release:Not true hypersensitivity
- ~~Codeine, morphine
-
Fixed Drug Eruption
- Sharply demarcated, dusky red plaques
- Present shortly after drug is started, reappear in the same place each time the drug is taken
- Prodromal itching or burning
- May occur anywhere on the skin, but the glans penis is the most common location
-
Fixed drug eruption dx
- Provocation challenge confirms the diagnosis
- May need to biopsy to r/o cutaneous T-cell lymphoma
-
Photosensitive Drug Reactions
- May be due to medicines administered internally or externally
- Phototoxic reaction
- Photoallergic rxn
-
Phototoxic drug rxn
- Dose dependent
- Limited to area of sun exposure
- Subsides when drug is stopped
- Occurs within 24 hours of exposure
-
Photoallergic drug reaction
- Less common
- No relation to dose
- Does not begin until about 48 hours after exposure
- May spread to non-sun exposed area
-
Acneiform rash
Steroids or hormones
-
Lupus-like rash
hydralazine, procainamide
-
Photosensitivity
thiazides, sulfonamides, tetracycline
-
Amiodarone
blue-grey in photodistribution
-
Minocycline
blue-grey on gingiva and teeth
-
Antimalarial
brown on the shins
-
Oral contraceptives
melasma on face
-
Rifampin
red man syndrome (high dose)
-
Drug Reaction - Treatment
- A good history is key!!
- D/C offending medication
- Antihistamines for pruritus
- Hospitalization and epinephrine for severe reaction
- Avoid other medicines in the class as well as other medicines that may cross react (i.e. sulfa and HCTZ)
-
Lichen Planus
- Inflammatory papulosquamous disease
- Etiology unknown
- May affect hair, skin, or mucous membranes
- 5 P's
-
5 ps lichen planus
- Pruritic
- Planar
- Polygonal
- Purple
- Papules
-
Lichen Planus - Clinical Presentation
- Small, flat topped papule with an irregular, angulated border
- May initially present as pinkish papules-"Purple Polygonal Papule"
- Surface of papule has white, reticulated pattern=Wickham's striae
- + Koebner's phenomenon
-
Types of lichen planus presentation
- Papular
- Hypertrophic
- Follicular
- mucosal
-
KOEBNERS Phenomenon
New lesions appear in area of trauma
-
Lichen Planus -papular
- Most common
- Papules on flexor surfaces of wrists, forearms, ankles, lumbar back
-
Hypertrophic LP
- Lesions become hypertrophic with coalescing papules
- Most common on the shins
- May form bullae
- Residual brown hyperpigmentation
-
Follicular LP (lichen planopilaris)
- Papules occur at the hair follicle - scalp
- Scarring causes hair loss
-
Mucosal Lichen Planus
- Non-erosive - lacy white reticulation
- Erosive - beefy red desquamation
- May involve penis or vagina
- 3% go on to develop oral SCC
-
LP - Diagnostic Evaluation
- Biopsy
- If scalp involved, obtain DIF to r/o cutaneous lupus
- Screen for Hep C
-
LP - Treatment
- Antihistamines for pruritus
- Class I or II steroids twice daily
- Intralesional steroid for hypertrophic plaques
- Dapsone, azathioprine, hydroxychloroquine for refractory cases
-
Pityriasis Rosea
- Common, self-limited rash lesions resolve over 4-12 weeks
- May be asymptomatic or cause mild pruritus
- Most patients are ages 10-35
- May be preceded by viral infection
- More common in Spring and Fall
- May have local outbreaks in close quarters
-
Pityriasis Rosea - Clinical Presentation
- HERALD PATCH
- 1-2 weeks later, multiple smaller lesions erupt
- Usually also have COLLARETTE OF SCALE
- CHRISTMAS TREE DISTRIBUTION
- Torso, upper arms, upper legs
- Rarely involves face
-
Herald patch
- Salmon-colored plaque occurs on chest or torso
- Thin collarette of scale along border
- Generally 1-2 cm in size
- ASSOC W/ PITYRIASIS ROSEA
- May mimic tinea
-
Pityriasis Rosea - Diagnostic Evaluation
- Clinical Diagnosis
- If lesions on palms and soles MUST test for syphilis
- ~~~Consider in other cases based on history and presentation
- Herald patch may mimic tinea - KOH to r/o
-
Pityriasis Rosea - Treatment
- Patient reassurance
- Antihistamines, topicals (low-medium potency steroids) for pruritus
-
Psoriasis
- Common, chronic inflammatory papulosquamous disease predominated by T-cell dysfunction and autoimmune dysregulation
- Genetic + environment
- Affects 1-3% of the population worldwide
-
Psoriasis - Pathophysiology
- Abnormal maturation of keratocytes in the skin
- Hyperkeratosis
- Cell nuclei in the stratum corneum are retained
-
Psoriasis - Triggers
- Stress
- Strep infection
- HIV infection
- Koebner phenomenon
- Drugs (lithium, antimalarials, steroid withdrawal)
-
Psoriasis forms
- Plaque
- Guttae
- Pustular
- inverse
-
Plaque psoriasis
- Most common form
- Red, sharply demarcated scaling papules
- May coalesce to form round to oval plaques
- Adherent silvery scale that bleeds when removed (Auspitz sign)
- Most common on extensor extremities, scalp, and sacrum
-
Guttae psoriasis
- Sudden appearance of multiple small psoriasiform papules on the torso
- Widespread
- May occur after Group A strep infection or viral infection
- Usually occurs in adults
- May be initial presentation of psoriasis
-
Pustular psoriasis
- Pustules form on palms and soles
- Painful, may be debilitating
- As reach surface, pustules become brown and scaly
- Also usually have associated nail changes
-
Inverse psoriasis
- Less common
- Typical erythematous plaques occur in flexural and intertriginous areas
- ~~Groin, axilla, inframammary folds
- May become macerated
- Diabetic patients or those on chronic steroids may develop secondary candida infection
-
Psoriasis sx
- Nail changes-Can occur with any form
- ~Pitting
- ~Onycholysis
- ~Oil drop sign
-
Psoriasis - Diagnostic Evaluation
- Clinical diagnosis
- Biopsy if unsure
- KOH to r/o fungal
- Consider ASO titer with flares of guttae psoriasis
- HIV test if significant, recalcitrant disease
- r/o strep-avoid rheum fever
-
Psoriasis - Treatment
- Topical
- Photo therapy
- Systemic
-
Topical-psoriasis tx
- Tar preparations
- Vitamin D analogues (Dovonex, Vectical)
- Topical steroids (Group I-V)-Cyclical treatments
- Retinoids (Tazorac)
-
Phototherapy psoriasis
- UVB 3-5 times/wk.
- Narrow band has fewer side effects but limited availability
- PUVA
-
Systemic psoriasis therapy
- Consider in patients with > 10% BSA or based on patient discomfort/disability
- Managed by dermatology
- Methotrexate
- Cyclosporin
- Acetretin (Soriataine)
- Biologics (Enbrel, Humira, Remicade &Stelara)
-
Psoriasis complications
- Both the disease itself as well as treatment may carry long-term effects
- Increased risk CAD
- AE from steroids or chronic immunosuppression
- AE from phototherapy
- Monitor lipids, HTN
- Regular skin cancer screenings
- Other f/u as warranted by their medications
- Desquamation and Hypersensitivity Syndromes
-
Erythema Multiforme
- Recurrent, inflammatory condition with "target" lesions
- Fairly common
- Commonly associated with HSV, Mycoplasma and URIs
- Less commonly seen with medications, internal malignancy
- Idiopathic in half of cases
-
Erythema Multiforme - Pathophysiology
Theorized to be immune system response against keratinocytes that present viral or drug antigens
-
Erythema Multiforme - Clinical Presentation
- Multiforme = multiple morphologies
- ~~Target lesions, macules, papules, urticarial, vesicles
- ~~NEED TO HAVE TARGET LESIONS TO DX CLINICALLY
- Pruritus and burning
- Sudden onset
- Palms, soles, hands, feet, distal arms and legs
-
Erythema Multiforme progression
- Crops of lesions appear
- Oral bullae or erosions
- Urticarial lesions last >24 hours
- + Koebner phenomenon
- +/- signs of accompanying infection
-
Erythema Multiforme - Diagnostic Evaluation
- May diagnose clinically if target lesions are present
- Biopsy
-
EM - Treatment
- Self limited - usually resolves within a month
- If associated with reactivations of HSV, may need suppressive therapy
- Systemic steroids if widespread
- Topical steroids if limited
-
Stevens-Johnson Syndrome
- Severe, blistering mucocutaneous syndrome
- Involves at least two mucous membranes
- Most common in children and young adults
-
Stevens-Johnson Syndrome - Pathophysiology
- Similar to erythema multiforme
- Immune response directed against keratinocytes that are expressing foreign antigens
-
SJS - Etiology
- Associated with Mycoplasma
- Medications
-
Sjs medications
- Phenytoin, phenobarbital, carbamazepine
- Sulfa drugs, PCNs
- Usually started within 1 month of onset
-
SJS - Clinical Manifestations
- Acute onset of erythematous papules, vesicles, purpura, and target lesions
- Skin is tender and burning
- Erosions and bullae develop on mucosa
- Central distribution on face and trunk
-
Sjs progression
- Lesions erupt over 10-14 days, improve over 3-4 weeks
- Fever and constitutional symptoms
- With increased skin break down, develop dehydration and are at risk for sepsis
-
SJS - Diagnostic Evaluation
- Biopsy: Necrosis of the full thickness of the epidermis, dermis remains intact
- Watch for S&Sx of infection: Wound culture &CBCs
- Often require hospitalization for fluid maintenance and monitoring for infection
-
SJS - Treatment
- Find the causative agent
- Maintain fluid and nutritional requirements
- Wound care
- Ophthalmology consult if eye involvement
- Burn care
- +/- systemic steroids
- Narcotics for pain
- IVIG
-
SJS - Prognosis
- With good supportive care, mortality is < 1%
- Recurrence rare unless exposed to causative drug again
-
Toxic Epidermal Necrolysis
- Life-threatening disease with blistering and sloughing of the skin and mucous membranes
- Most often caused by medication: Within 1-3 weeks before onset
- ~~~~~Sulfa, antimalarials, anticonvulsants, NSAIDs, allopurinol
- Other causes triggered by recent immunization or infection
-
TEN - Pathophysiology
- Cause - unknown
- Skin sloughing theorized to be due to increased apoptosis
-
TEN - Clinical Manifestations
- Begins as diffuse "sunburn" and tenderness
- Scattered target lesions and bullae form
- Bullae coalesce to cause widespread sloughing
- Painful erosions on mucous membranes
- +Nikolsky sign
- May have non-skin findings similar to SJS
-
TEN - Diagnostic Evaluation
Bx to r/o staph scalded skin syndrome
-
TEN - Treatment
- Control pain
- Find the cause
- Burn care
- Maintain fluid and nutrition
- IVIG
- Steroids? Use with prophylactic antibiotics
- May require other immunosuppressant therapy
-
TEN - Prognosis
- Mortality rate 30-50%
- d/2 complications-infection etc
-
Acanthosis Nigricans
- Thick, velvety plaques
- neck, groin and axillae
- patients w/ abnormal glucose metabolism or malignancy (rare)
-
Acanthosis Nigricans - Etiology/Pathophysiology
- Not fully understood
- Related to insulin resistance
-
Acanthosis Nigricans - Clinical Presentation
- Gradual onset of thickened, hyperpigmented skin
- Brown or tan thickened, velvety
- Most commonly seen on the back of neck and axillae
- May also be seen in the inguinal creases
- May have multiple skin tags associated
-
Acanthosis Nigricans - pt
- Look for other signs of insulin resistance
- ~~Obesity
- ~~PCOS characteristics in women
-
Acanthosis nigicans-malignancy
- High suspicion if doesn't fit "typical" picture
- Rarely sign of internal malignancy
- (90% in the abdomen)
- ~~Middle aged patient
- ~~Abrupt onset
- ~~Not obese
-
Acanthosis Nigricans - Diagnostic Evaluation
- Clinical Diagnosis
- Evaluate for insulin resistance
-
Acanthosis Nigricans - Treatment
- Retinoids, dermabrasion
- Treat underlying condition
- ~~Treat insulin resistance/excess
- ~~Weight loss
- ~~Screen/treat for malignancy
-
Granuloma Annulare
- Common skin condition with smooth, discolored plaques
- Most common in children and teenagers, but can occur at any age
- Asymptomatic - mildly tender if bumped
- May mimic tinea
-
Granuloma Annulare - Etiology/Pathophysiology
- Delayed hypersensitivity reaction to component of the dermis
- Mediated by TNF-a
- Trigger unknown
- Local disease may be associated with thyroid disorder
- Widespread disease may be associated with DM, hyperlipidemia, lymphoma, solid tumors
-
Granuloma Annulare - rash
- Begins as erythematous papule
- Expands to annular, erythematous plaque
- Raised, papular border
- Center is flatter, lighter colored
-
Granuloma Annulare - distribution
- May occur anywhere on the body
- More likely to occur on skin around joints
- Localized, occasionally widespread (more common in adults)
- Clears on its own over months-years
-
Granuloma Annulare - Diagnostic Evaluation
- KOH to r/o fungal infection if needed
- Clinical diagnosis, but may bx to confirm
-
Granuloma Annulare - Treatment
- Self limited
- Steroid (high potentcy)
- Intralesional steroid
- Disemminated disease
- ~~Isotretinoin, methotrexate, dapsone, hydroxychloroquine
-
Hidradenitis Suppurativa
- Inflammatory skin condition affecting areas with apocrine sweat glands
- Recurrent nodules and abscesses that have sinus tracts
-
Hidradenitis Suppurativa - Etiology/pathophysiology
- Exact cause unknown
- Characterized by follicular occlusion
- Apocrine gland ducts are occluded causing inflammation
- Follicle ruptures, forms abscess
- Sinus tracts form between abscesses
-
Hidradenitis Suppurativa - Aggravating factors
- Genetics
- Female > male
- Obesity, PCOS
- Pro-inflammatory cytokines
- Cigarette smoking
- Secondary bacterial infection
-
Hidradenitis Suppurativa - Clinical Presentation
- Multiple, deep-seated cysts in the axillae and groin
- Often have sinus tracts and two openings
- Cysts tend to have chronic, low-level inflammation
- occasionally develop 2ndry infection and cause increase in pain, swelling, and discharge
- axillae, inframammary folds, neck, groin, perianal folds
-
Hidradenitis Suppurativa - Diagnostic Evaluation
Clinical diagnosis
-
Hidradenitis Suppurativa - Treatment
- Earlier treatment is better
- d/c smoking
- Weight reduction
- Hair removal
- Topical antiseptic soaps
-
Hidradenitis Suppurativa - meds
- Clindamycin/benzoyl peroxide topical
- Tetracyclines for prolonged courses
- Spironolactone
- Isotretinoin 6-12 months
- TNF inhibitors for severe disease
- I&D inflamed abcesses for pain reduction
- Surgical debulking
-
Lipomas
- Common, benign tumors consisting of adipose cells
- Located within the subcutaneous tissue
-
Lipomas - Etiology/Pathophysiology
- Cause unknown
- Genetic predisposition, especially in patients with multiple lipomas
- Blunt trauma may trigger solitary lipoma, but most often cause is unknown
-
Lipomas - Clinical Presentation
- Very slow growth of soft, palpable nodule beneath the skin
- Smooth, not fixed to underlying tissue
- Most common on the neck, trunk, and arms
- Usually asymptomatic but may have tenderness with palpation
-
Lipomas - Diagnostic Evaluation
- Clinical Diagnosis
- May be removed for cosmetic reasons (general surgery?)
- If quickly enlarging or painful, consider biopsy to r/o liposarcoma
-
Lipomas - Treatment
- Surgical excision
- Squeeze technique
- Liposuction
-
Epithelial Inclusion Cysts
- Epidermal cysts
- Pilar cysts
-
Epidermal cysts
cystic structure filled with soft, cheese-like keratinous contents
-
Pilar cysts
- small cysts on the scalp
- filled w/ firm, white content
- arise from the hair root sheath
-
Epithelial Inclusion Cysts - Etiology/Pathophysiology
- May result from plugging of sebaceous glands with oil backing up
- Body "walls off" debris, which is retained
-
Epidermal cysts ssx
- well-circumscribed cystic lesion
- May have tract open to the skin
- Firm, not fixed to underlying tissue
- When inflamed, may become more fluctuant and tender, red
- May spontaneously open and drain
-
Pilar cysts ssx
- Well, circumscribed, firm nodules on the scalp
- Usually multiple
- Not attached to underlying tissue
- Usually do not spontaneously open and drain unless secondarily infected
-
Epithelial Inclusion Cysts - Diagnostic Evaluation
- Not usually necessary
- Bacterial culture if infected
-
Epithelial Inclusion Cysts - Treatment
- No treatment if small (<5 mm)
- Try to avoid treatment when inflamed
- I&D, treat with antibiotics
- Return for excision of sac when quiet
- Excision of cyst best chance to avoid recurrence, but this may still occur
-
Melasma
- Hyperpigmentation of the face
- Typically occurs in women during pregnancy and on OCPs
- More common in darker skin types
-
Melasma - Clinical Presentation
- Hyperpigmented macules - sharply demarcated with an irregular border
- May be brown, tan, blue-gray
-
Melasma - Diagnostic Evaluation
- Clinical Diagnosis
- Biopsy suspicious area
-
Melasma - Treatment
- If due to pregnancy, may resolve after pregnancy
- May recur with subsequent pregnancies
- Hydroquinone
- Laser
-
Pilonidal Disease
- Chronic sinus tract in the sacrococcygeal region
- filled with nests of hair
- May become infected and inflamed
-
Pilonidal Disease - Etiology/Pathophysiology
- Congenital - pits or dimples at the base of the spine
- Higher risk if prone to follicular plugging
- With friction, follicles are injured and hair protrudes into surrounding skin
- Skin and perineal bacteria invade and cause infection
- S. aureus or Bacteroides
-
Pilonidal disease - Risk Factors
- M>F
- Obesity
- Genetics
- Poor hygiene
- Prolonged sitting or friction on the buttocks
- Repeated injury to the area
- Coexisting hidradenitis suppurativa
-
Pilonidal disease - Clinical Presentation
- May be asymptomatic - pit or dimple at the base of the spine
- Develop tenderness in the area after prolonged sitting
- Pain, redness, swelling of the skin
- Small holes that drain fluid (clear, cloudy, or pus-like)
- Fever, malaise, or nausea
- May have visible tracts with recurrent disease
-
Pilonidal Disease - Diagnostic Evaluation
Clinical Diagnosis
-
Pilonidal Disease - Treatment
- Keep area clean, free of hair
- I&D
- Excision of tract
- Marsupialization of cyst
-
Pressure Ulcers
- Bed sores, decubitus ulcers
- Area of reddened skin
- progresses to skin breakdown that results in sores and ulcers
-
Pressure Ulcers - Etiology/Pathophysiology
- Due to lack of blood flow and mechanical stress to the skin over a bony area
- Occurs when area has been under pressure for a prolonged period
- If blood supply cut off for 2-3 hours, skin is deprived of oxygen and begins to die
- Exposure to irritants increases risk
-
Pressure Ulcers - Risk Factors
- Immobility
- Peripheral neuropathy
- Elderly
-
Ulcers Stage 1
- Skin is red or pink but unbroken
- May look like a mild sunburn
- Tender, itchy or painful
-
Ulcers Stage 2
- Skin is red, swollen, and painful
- Blisters present (intact or broken)
- Upper layers of skin begin to die
-
Ulcers Stage 3
- Skin is broken, wound extends down to deeper layers of skin
- Crater-like ulcers present
- Wound is prone to infection
-
Ulcers Stage 4
- Sore extends into deeper tissue
- Necrosis and eschar in deep, opened wound
-
Pressure Ulcers - Diagnostic Evaluation
Clinical diagnosis
-
Pressure Ulcers - Treatment
- Prevent, treat early
- Treatment by wound care
- Topical vac therapy
- Hyperbaric oxygen
- Hydrotherapy
- Debridement
- Treat infection
-
Urticaria
- Wheals resulting from edema of the dermal tissue
- Angioedema results from edema of deeper structures
-
Acute urticarial path/etiology
- (< 6 weeks)
- Post viral
- Allergic reaction (IgE mediated)
-
Chronic urticarial path/etiology
- (> 6 weeks)
- Allergic (chronic exposure)
- Autoimmune (lupus, vasculitis, thyroid)
- Idiopathic (~50%)
-
Urticaria - Clinical Presentation
- Pruritic wheals, often confluent
- Angioedema is swelling of deeper cutaneous tissue
- Hands, feet, lips, eyelids, genitalia
- Lesions evolve over hours
- Pruritus and/or burning
- May be exacerbated by heat, cold stress, pressure
-
Urticaria - Concerning characteristics
- Individual lesions last >24 hours
- Burning sensation
- Residual bruising
- (especially with chronic urticaria)
-
Chronic urticaria
- Individuals with chronic urticaria may have specific triggers
- Cold induced urticaria, heat induced urticaria
- Dermatographism
-
Acute Urticaria dx
- No labs needed
- Review medication history, exposures
- Any signs/sx of viral infection?
-
Chronic urticarial dx
- CBC, CMP, Complements
- IgE, ANA, TSH, thyroglobulin antibody, thyroid peroxidase antibody
- Sed rate
- Consider evaluation with allergist for allergy testing
-
Urticaria - Treatment
- Avoid heat, pressure
- NSAIDS may enhance rxn
- d/c any potentially triggering meds
- Treat underlying causes of chronic urticaria
- Antihistamines
- Steroids
- Epinephrine
-
Antihistamines-urticaria
- Long-acting antihistamine (Zyrtec, Claritin) - can use once or twice daily
- Benadryl as needed for breakthrough symptoms
- May add H2 blocker
-
Steroids-urticaria
- Consider oral steroid for severe outbreak
- Topical steroids DO NOT help
-
Epinephrine-urticaria
May be needed for angioedema if airway is compromised
-
Vitiligo
Acquired condition where impaired or absent melanocyte function leads to hypopigmentation of the skin
-
Vitiligo - Etiology/Pathophysiology
- Exact mechanism unknown - autoimmune
- May be associated with thyroid disorder, pernicious anemia, Addison's disease
- Usually starts between age 10-30
- Melanocyte function is impaired or absent
-
Vitiligo - Clinical Presentation
- Asymptomatic
- Small white macule expands in size
- May affect any part of the body
- May cause depigmentation of the hair if hairy area is affected
- Affected skin is depigmented and sharply demarcated
- Use Wood's lamp to evaluate
-
Vitiligo distribution
- Most commonly affected
- Extensor bony surfaces
- Periorificial areas
-
Vitiligo - Diagnostic Evaluation
- May biopsy if in question
- CBC, TSH to screen for underlying disorder
-
Vitiligo - Treatment
- Very difficult to treat
- Only 15-20% have full resolution
- 20% show no improvement
- Earlier treatment has better results
- Topical steroids - watch for AE
- PUVA or UVB therapy
- Cosmetics to cover affected areas
-
Erythema Nodosum
Inflammatory panniculitis with erythematous, deep nodules on the shins
-
Erythema Nodosum - Etiology/Pathophysiology
- Panniculitis - inflammation of the subcutaneous fat
- Most common ages 20-30, Women >> Men
- Some cases preceeded by infection or illness
- Appears to be hypersensitivity reaction
-
Erythema Nodosum - Risk Factors
- Pharyngitis
- Mycoplasma infection
- Sarcoidosis
- Tuberculosis
- Pregnancy or OCPs
- Meds - sulfa, ASA, NSAIDs
- Inflammatory bowel disease
-
Erythema Nodosum - Clinical Presentation
- Erythematous nodules appear on shins (6-12)
- Painful nodules erupt over 10 days
- Become smaller and darker purple as they age
- Aching and swelling of the legs may last 3-6 weeks
- May have systemic symptoms when first starts
- Arthralgias, rarely conjunctivitis
-
Erythema Nodosum - Diagnostic Evaluation
- Clinical diagnosis
- Biopsy may be helpful (have to get subcutaneous fat)
- Check for other risk factors
- Throat culture
- CBC, CRP, ESR
- ASO titer
- Consider screening for TB
-
Erythema Nodosum - Treatment
- Treat underlying infection
- Rest if pain or swelling is severe
- Compression, ice
- NSAIDs
|
|